News
COMPETE Clinical Trial
A new phase III clinical trial called COMPETE (NCT03049189 ) compares everolimus, an oral targeted therapy, to PRRT with Lu-177 edotreotide, a radiopharmaceutical under development,
Coping with Loss During the Holidays
Following the loss of a loved one, holiday traditions may be more painful than joyful. Many things can trigger memories that seem to amplify your
A Look at Lung NETs
Approximately 20% of all primary lung tumors are neuroendocrine (Hung 2019), including: Typical carcinoid (TC) Atypical carcinoid (AC) Small cell carcinoma (SCC) Large cell carcinoma
Retrospective Art Show Benefits NETRF
The late Carl Schaad captured on canvas the beauty of New England and Italy, with expansive landscapes and small still life. Family and friends gathered
NETRF-funded Research Included Among 2019’s Most Important Developments
Highlights from NANETS 2019 symposium where leading NET experts presented progress and identified priorities for moving NET knowledge and care forward.
Staying Safe from the Flu
Living with cancer increases your risk for complications from influenza (“flu”). If you have cancer now, have had cancer in the past, or live with
A Great Day for a Victory Lap
Almost 2 years after his NET diagnosis, Maros Felsen organizes and runs a 5K neuroendocrine cancer fundraiser. He’s proof for all that you can lead an active, meaningful, and successful life with neuroendocrine cancer.
Biking for Debbie
Vicki Dailey organizes an annual two-state, 82-mile bikeride to honor her sister’s experience with neuroendocrine cancer to move us closer to a cure.
Painting the Town Zebra-Striped
A small town in Maine finds its zebra stripes after two first responders and a town official succumbed to NETs since 2017. See how they are raising awareness and money for research.
She Doesn’t Look Like She Has Cancer
Dr. Elizabeth Zide vs. Neuroendocrine Cancer Members “Nothing But NET” marathon relay team. (left to right) Elizabeth Zide, Alaina Kronenberg, and Cassi Cohen. Her lifestyle